SCHEMBL28611570

SCHEMBL28611570

CC(C)c1ccc2c(c1)C(c1ccccc1)C(c1ccccc1)C2=O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.37
KIF11 P52732 1/20 0.36
TNKS O95271 1/20 0.36
TNKS2 Q9H2K2 1/20 0.36
PARP3 Q9Y6F1 1/20 0.36
PDK2 Q15119 1/20 0.36
MAPT P10636 3/20 0.34
HPGD P15428 3/20 0.34
MAPK1 P28482 2/20 0.34
KDM4E B2RXH2 2/20 0.34
ALDH1A1 P00352 2/20 0.34
HTT P42858 2/20 0.34
CETP P11597 4/20 0.34
TP53 P04637 2/20 0.34
CYP3A4 P08684 2/20 0.34
CYP1A2 P05177 1/20 0.34
HTR2B P41595 1/20 0.34
NR1H3 Q13133 1/20 0.34
RNASEH1 O60930 1/20 0.33
GFER P55789 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28607133 0.79 CYP19A1 (0.48) LMNAMAPTHPGDMAPK1KDM4E
SCHEMBL28619622 0.76 CYP19A1 (0.43) LMNAMAPTHPGDMAPK1ALDH1A1
SCHEMBL28607117 0.76 MAOB (0.44) LMNAMAPTMAPK1HTTTP53
SCHEMBL28614063 0.76 CYP1A2 (0.44) LMNAMAPTMAPK1ALDH1A1TP53
SCHEMBL28414867 0.75 ESR2 (0.53) LMNAMAPTHPGDALDH1A1TP53
SCHEMBL28609468 0.75 ALDH1A1 (0.47) LMNAKIF11TNKSTNKS2PARP3
SCHEMBL10069656 0.74 KDM4E (0.55) LMNAKIF11TNKSTNKS2PARP3
SCHEMBL8117184 0.74 CYP1A2 (0.50) LMNATNKS2PARP3MAPTHPGD
SCHEMBL28619619 0.73 GPR3 (0.39) LMNAKIF11MAPTMAPK1ALDH1A1
SCHEMBL4423401 0.73 ESR2 (0.57) TNKS2MAPTHPGDALDH1A1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109574818-B Polysubstituted indanone derivative and preparation method thereof 华侨大学 2021-08-03 CN disclosed